Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Incyte paused enrollment for INCB000262, a drug being tested for chronic urticaria, due to concerning toxicology results from an animal study.
Incyte suspends enrollment in the Phase II study of INCB000262 for chronic spontaneous urticaria due to preclinical toxicology findings.
Incyte has paused enrollment in its Phase 2 study of MRGPRX2 (INCB000262) for chronic spontaneous urticaria due to preclinical toxicology findings.